OXETORONE

ID: ALA3989752

Chembl Id: CHEMBL3989752

Cas Number: 26020-55-3

PubChem CID: 36846

Max Phase: Phase

Molecular Formula: C21H21NO2

Molecular Weight: 319.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms from Alternative Forms(2): Oxetorone fumarate | L-6257

Canonical SMILES:  CN(C)CCC=C1c2ccccc2OCc2c1oc1ccccc21

Standard InChI:  InChI=1S/C21H21NO2/c1-22(2)13-7-10-17-15-8-3-5-11-19(15)23-14-18-16-9-4-6-12-20(16)24-21(17)18/h3-6,8-12H,7,13-14H2,1-2H3

Standard InChI Key:  VZVRZTZPHOHSCK-UHFFFAOYSA-N

Alternative Forms

  1. Alternative Forms:

  2. Parent:

    ALA3989752

    OXETORONE

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 319.40Molecular Weight (Monoisotopic): 319.1572AlogP: 4.71#Rotatable Bonds: 3
Polar Surface Area: 25.61Molecular Species: BASEHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.76CX LogP: 3.92CX LogD: 1.59
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.70Np Likeness Score: 0.23

References

1. WHO Anatomical Therapeutic Chemical Classification,